Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden

Robert F. Cornell, Raphael Fraser, Luciano Costa, Stacey Goodman, Noel Estrada-Merly, Cindy Lee, Gerhard Hildebrandt, Usama Gergis, Nosha Farhadfar, César O. Freytes, Rammurti T. Kamble, Maxwell Krem, Robert A. Kyle, Hillard M. Lazarus, David I. Marks, Kenneth Meehan, Sagar S. Patel, Muthalagu Ramanathan, Richard F. Olsson, John L. WagnerShaji Kumar, Muzaffar H. Qazilbash, Ninah Shah, Parameswaran Hari, Anita D'Souza

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden'. Together they form a unique fingerprint.

Medicine & Life Sciences